Current and historical daily PE Ratio for Giant Biogene Holding Co Ltd (
HKSE:02367
) from 2022 to May 25 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Giant Biogene Holding stock (HKSE:02367) PE ratio as of May 25 2024 is 30.73.
More Details
Giant Biogene Holding Co Ltd (HKSE:02367) PE Ratio (TTM) Chart
Giant Biogene Holding Co Ltd (HKSE:02367) PE Ratio (TTM) Historical Data
View and export this data going back to 2022. Start your Free Trial
Total 381
- 1
- 2
- 3
- 4
- 5
| Giant Biogene Holding PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-25 | 30.9 | 2024-03-18 | 26.6 |
| 2024-05-24 | 30.9 | 2024-03-15 | 25.6 |
| 2024-05-23 | 31.6 | 2024-03-14 | 25.9 |
| 2024-05-22 | 31.7 | 2024-03-13 | 24.8 |
| 2024-05-21 | 31.8 | 2024-03-12 | 24.9 |
| 2024-05-20 | 30.6 | 2024-03-11 | 24.1 |
| 2024-05-17 | 30.8 | 2024-03-08 | 22.2 |
| 2024-05-16 | 32.7 | 2024-03-07 | 21.9 |
| 2024-05-14 | 32.8 | 2024-03-06 | 22.4 |
| 2024-05-13 | 32.1 | 2024-03-05 | 22.0 |
| 2024-05-10 | 32.5 | 2024-03-04 | 22.8 |
| 2024-05-09 | 32.7 | 2024-03-01 | 22.1 |
| 2024-05-08 | 32.3 | 2024-02-29 | 22.1 |
| 2024-05-07 | 32.5 | 2024-02-28 | 21.7 |
| 2024-05-06 | 32.1 | 2024-02-27 | 22.2 |
| 2024-05-03 | 31.0 | 2024-02-26 | 22.2 |
| 2024-05-02 | 30.0 | 2024-02-23 | 22.4 |
| 2024-04-30 | 29.6 | 2024-02-22 | 22.2 |
| 2024-04-29 | 28.5 | 2024-02-21 | 22.0 |
| 2024-04-26 | 29.7 | 2024-02-20 | 21.6 |
| 2024-04-25 | 29.5 | 2024-02-19 | 21.4 |
| 2024-04-24 | 29.6 | 2024-02-16 | 22.0 |
| 2024-04-23 | 29.6 | 2024-02-15 | 22.2 |
| 2024-04-22 | 29.4 | 2024-02-14 | 22.0 |
| 2024-04-19 | 29.1 | 2024-02-09 | 20.7 |
| 2024-04-18 | 29.2 | 2024-02-08 | 20.6 |
| 2024-04-17 | 28.4 | 2024-02-07 | 20.3 |
| 2024-04-16 | 26.9 | 2024-02-06 | 19.9 |
| 2024-04-15 | 27.5 | 2024-02-05 | 18.1 |
| 2024-04-12 | 27.1 | 2024-02-02 | 19.3 |
| 2024-04-11 | 26.3 | 2024-02-01 | 19.7 |
| 2024-04-10 | 26.2 | 2024-01-31 | 19.6 |
| 2024-04-09 | 25.9 | 2024-01-30 | 20.2 |
| 2024-04-08 | 26.7 | 2024-01-29 | 20.6 |
| 2024-04-05 | 26.6 | 2024-01-26 | 20.9 |
| 2024-04-03 | 26.6 | 2024-01-25 | 21.4 |
| 2024-04-02 | 27.1 | 2024-01-24 | 21.1 |
| 2024-03-28 | 26.3 | 2024-01-23 | 20.5 |
| 2024-03-27 | 26.3 | 2024-01-22 | 20.1 |
| 2024-03-26 | 26.3 | 2024-01-19 | 20.5 |
| 2024-03-25 | 26.7 | 2024-01-18 | 21.0 |
| 2024-03-22 | 26.4 | 2024-01-17 | 20.9 |
| 2024-03-21 | 26.7 | 2024-01-16 | 21.7 |
| 2024-03-20 | 25.9 | 2024-01-15 | 22.2 |
| 2024-03-19 | 26.5 | 2024-01-12 | 21.9 |
Giant Biogene Holding Co Ltd (HKSE:02367) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Giant Biogene Holding Co Ltd
ISIN : KYG3887G1091
Share Class Description:
HKSE:02367: Ordinary SharesCompare
Compare
Traded in other countries / regions
02367.Hong Kong IPO Date
2022-11-04Description
Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers